These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Rapid intervention for an episode of malignant hyperthermia. Chartrand D Can J Anaesth; 2003 Feb; 50(2):104-7. PubMed ID: 12560297 [No Abstract] [Full Text] [Related]
6. Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle. Sudo RT; Carmo PL; Trachez MM; Zapata-Sudo G Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):308-16. PubMed ID: 18047479 [TBL] [Abstract][Full Text] [Related]
7. Ryanodex--A New Dantrolene Formulation for Malignant Hyperthermia. Med Lett Drugs Ther; 2015 Jul; 57(1472):100. PubMed ID: 26147894 [No Abstract] [Full Text] [Related]
8. Hyperthermia in the pediatric intensive care unit--is it malignant hyperthermia? Schleelein LE; Litman RS Paediatr Anaesth; 2009 Nov; 19(11):1113-8. PubMed ID: 19694974 [TBL] [Abstract][Full Text] [Related]
10. [Dantrolene. Pharmacological and therapeutic aspects]. Gerbershagen MU; Fiege M; Krause T; Agarwal K; Wappler F Anaesthesist; 2003 Mar; 52(3):238-45. PubMed ID: 12666006 [TBL] [Abstract][Full Text] [Related]
11. Stability of doripenem in vitro in representative infusion solutions and infusion bags. Psathas PA; Kuzmission A; Ikeda K; Yasuo S Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795 [TBL] [Abstract][Full Text] [Related]
12. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006. Larach MG; Gronert GA; Allen GC; Brandom BW; Lehman EB Anesth Analg; 2010 Feb; 110(2):498-507. PubMed ID: 20081135 [TBL] [Abstract][Full Text] [Related]
14. Prediction of accelerated Ca-induced Ca release rate by clinical findings in malignant hyperthermia susceptible subjects. Kawamoto M; Mukaida K; Maehara Y; Yuge O In Vivo; 2001; 15(1):45-8. PubMed ID: 11286128 [TBL] [Abstract][Full Text] [Related]
15. Stability of aqueous solutions of amoxicillin sodium in the frozen and liquid states. Concannon J; Lovitt H; Ramage M; Tai LH; McDonald C; Sunderland VB Am J Hosp Pharm; 1986 Dec; 43(12):3027-30. PubMed ID: 3812510 [TBL] [Abstract][Full Text] [Related]
16. Stability of cefazolin sodium in various artificial tear solutions and aqueous vehicles. Ahmed I; Day P Am J Hosp Pharm; 1987 Oct; 44(10):2287-90. PubMed ID: 3687969 [TBL] [Abstract][Full Text] [Related]
17. Kinetics of the chemical oxidation of polysulfide anions in aqueous solution. Kleinjan WE; de Keizer A; Janssen AJ Water Res; 2005 Oct; 39(17):4093-100. PubMed ID: 16213542 [TBL] [Abstract][Full Text] [Related]
19. Effect of 2-hydroxypropyl-beta-cyclodextrin on the solubility, stability, and pharmacological activity of the chemical delivery system of TRH analogs. Wu WM; Wu J; Bodor N Pharmazie; 2002 Feb; 57(2):130-4. PubMed ID: 11878189 [TBL] [Abstract][Full Text] [Related]